49635-47-4

Basic information

• Product Name: 10-methyl-4,6-dioxo-1,4,6,9-tetrahydropyrido[3,2-g]quinoline-2,8-dicarboxylic acid
• CAS NO: 49635-47-4
• Molecular Formula: C₁₅H₁₀N₂O₆
• Molecular Weight: 314.2497
• Mol File: 49635-47-4.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 599.5°C at 760 mmHg
• Flash Point: 316.4°C
• Density: 1.641g/cm³
• Vapor Pressure: 3.19E-15mmHg at 25°C
• Refractive Index: 1.697
• CAS DataBase Reference: 10-methyl-4,6-dioxo-1,4,6,9-tetrahydropyrido[3,2-g]quinoline-2,8-dicarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 10-methyl-4,6-dioxo-1,4,6,9-tetrahydropyrido[3,2-g]quinoline-2,8-dicarboxylic acid(49635-47-4)
• EPA Substance Registry System: 10-methyl-4,6-dioxo-1,4,6,9-tetrahydropyrido[3,2-g]quinoline-2,8-dicarboxylic acid(49635-47-4)

Safety Data

• Hazardous Substances Data: 49635-47-4(Hazardous Substances Data)

Usage

Molecular structure

10-methyl-4,6-dioxo-1,4,6,9-tetrahydropyrido[3,2-g]quinoline-2,8-dicarboxylic acid has a complex fused ring structure with a quinoline core.

Functional groups

The compound contains two carboxylic acid groups, which are important functional groups in organic chemistry.

Potential applications

It may have potential applications in medicinal chemistry and drug development due to its unique structure and functional groups.

Building block

The compound could potentially be used as a building block for the synthesis of novel pharmaceutical compounds.

Biological activity

It may have biological activity itself that could be of interest for further study.

Research implications

10-methyl-4,6-dioxo-1,4,6,9-tetrahydropyrido[3,2-g]quinoline-2,8-dicarboxylic acid has a complex structure and may have important implications for chemical and pharmaceutical research.

Upstream product

• 49635-43-0 2,6-bis(1,2-dicarbomethoxyvinylamino)toluene 
• 823-40-5 2,6-toluenediamine 
• 49635-42-9 1,4,6,9-tetrahydro-2,8-dicarbomethoxy-10-methylpyrido<3,2-g>quinoline-4,6-dione 

Relevant articles and documents

Structure-Activity Relationship Studies of Coumarin-like Diacid Derivatives as Human G Protein-Coupled Receptor-35 (hGPR35) Agonists and a Consequent New Design Principle

A series of coumarin-like diacid derivatives were designed and synthesized as novel agonists of human G-protein-coupled receptor 35 (hGPR35). Active compounds were characterized to possess one acidic group on both sides of a fused tricyclic aromatic scaff

Derivatives of 4,6 dioxopyrido[3,2-g]quinoline 2,8 dicarboxylic acid

Novel chemical compounds of the formula: SPC1 Wherein R is selected from the group consisting of hydrogen, alkyl from one to three carbon atoms, inclusive, phenyl, alkali metal, or an amine cation; X and Y can be the same or different and are selected from the group consisting of hydrogen, alkyl of from one to six carbon atoms, inclusive, cycloalkyl of 5 or 6 carbon atoms, inclusive, phenyl, hydroxyl, alkoxy having from one to three carbon atoms, inclusive, halogen, trifluoromethyl, cyano, carboxyamide and O C-OQ, EQU1 where Q is selected from the group consisting of hydrogen, alkyl from one to three carbon atoms, inclusive, alkali metal, and an amine cation, with the proviso that where R is hydrogen, alkali metal or an amine cation, then Q is the same as R, and where R is phenyl or alkyl from one to three carbon atoms, then Q is phenyl or alkyl from one to three carbon atoms; and Z is selected from the group consisting of hydrogen, alkyl from one to three carbon atoms, inclusive, and phenyl. The compounds are formulated with pharmaceutical carriers for oral or parenteral administration, with insufflation being the preferred method. The compositions are useful in the prophylactic treatment of sensitized humans and mammals for allergy and all anaphylactic reactions of a reagin or non-reagin mediated nature.